Latest News

Activist AREX Capital poised to win one seat in proxy fight at Enhabit, sources say

AREX Capital Management has secured enough support from Enhabit investors to win one seat on the home health and hospice supplier's board of directors, people knowledgeable about the matter said on Thursday.

Investor votes are still being counted before Enhabit's. annual conference of shareholders on Thursday early morning. AREX. nominated seven prospects to Enhabit's nine-member board.

The seat is anticipated to go to Mark Ohlendorf, who has public. company chief monetary officer experience.

The project is among only a handful of proxy battles to go. to a vote this year after Disney defeated Trian Fund. Management in April. In May Norfolk Southern. investors chose three of activist investor Ancora Holdings'. candidates to the railroad's board.

Proxy advisory companies Institutional Investor Providers. ( ISS) and Glass Lewis advised investors to change three. present board members with AREX candidates. The 2 groups'. recommendations typically assist investors in ballot on hot-button. problems consisting of proposed mergers and who sits on a board,

Enhabit's share price has tumbled roughly 60% considering that it. was spun off of post-acute healthcare providers. Encompass Health in July 2022. It has climbed almost 10%. in the last 5 days and is up 3.5% in early trading on Thursday.

AREX, which owns a 4.9% stake in Enhabit, is the most recent. activist financier to press the business for modifications and advised. management last year to right away begin a strategic review. Enhabit in May decided to continue as an independent.

In 2023, the company reached a settlement with Cruiser. Capital and Harbour Point Capital Management and appointed 2. new directors to the board.

(source: Reuters)